Secure-24, an NTT Communications Company, to Acquire Symmetry, Leading SAP Managed Service Provider in the U.S.
NTT Communications Corporation (NTT Com), the ICT solutions and international communications business within the NTT Group (TOKYO:9432), and Symmetry Holding Inc. (Symmetry), a U.S.-based leading provider of SAP managed services, announced today that Secure-24 Intermediate Holdings, Inc. (Secure-24), wholly owned subsidiary of NTT Com, entered into a definitive agreement on June 26 (Japan Standard Time), pursuant to which Secure-24 will wholly acquire Symmetry.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190625006084/en/
Managed services are one of the key capabilities NTT Com is strengthening to support its clients’ digital transformations as a DX Enabler™. Secure-24 has been playing key roles for delivering such capabilities especially in the U.S. market. Symmetry possesses extensive expertise in SAP managed services, which it delivers to large enterprise clients in diverse industries including consumer products, life sciences, manufacturing and high-tech in the U.S., the world’s largest market for managed services. Symmetry also offers migration and operations services for SAP S/4 HANA, a flexible, high-speed platform, which is expected to be widely deployed.
“The acquisition of Symmetry allows us to strengthen the comprehensive managed services we provide to our customers, while opening doors to new opportunities,” said Mike BeDell, Chief Executive Officer, Secure-24. “With the combined expertise of both companies and Symmetry’s extensive portfolio of managed SAP services we are now in a position to deliver greater value to our customers around the world.”
“For more than 20 years, Symmetry has been committed to delivering the highest quality SAP cloud hosting and application management services to the market and our customers,” said Pete Stevenson, Chairman and CEO of Symmetry. “We look forward to delivering even greater value to our customers with the expanded offerings and global resources that Secure-24 offers, without sacrificing the high touch support and commitment to success our team executes on and our customers have come to expect.”
The transaction is expected to close in 2019 and is subject to regulatory approvals. Through this 100 percent acquisition, Symmetry’s unique strengths will be fully integrated into the NTT Com ecosystem, including its total managed IT service, as well as cloud, network and data center services, for increasingly robust managed operation and maintenance of clients’ hybrid IT environments.
NTT Com will continue to enhance its technical and business systems to sustainably deliver managed services that drive digital transformation for clients.
|
Overview of Symmetry |
|
|
|
|
|
Corporation: |
Symmetry Holding Inc. |
|
Established: |
1998 |
|
Chairman & CEO: |
Pete Stevenson |
|
Headquarters: |
Wisconsin, USA |
|
Business: |
IT managed services focused on SAP |
|
Main industries: |
Consumer products, life sciences, manufacturing and high-tech |
About NTT Communications
NTT Communications solves the world’s technology challenges by helping enterprises overcome complexity and risk in their ICT environments with managed IT infrastructure solutions. These solutions are backed by our worldwide infrastructure, including industry leading, global tier-1 public and private networks reaching over 190 countries/regions, and more than 400,000m2 of the world’s most advanced data center facilities. Our global professional services teams provide consultation and architecture for the resiliency and security required for your business success, and our scale and global capabilities are unsurpassed. Combined with NTT Data, NTT Security, NTT DOCOMO and Dimension Data, we are NTT Group.
www.ntt.com |
Twitter@NTTcom
|
Facebook@NTTcom
|
LinkedIn@NTTcom
About Secure-24
Secure-24, an NTT Communications Company, has 18 years of experience delivering mission critical application hosting, comprehensive managed IT, and cloud services to enterprises worldwide. Secure-24’s focus on superior service, support, governance and compliance has driven industry-leading client satisfaction rates. The company is an SAP certified Hosting, HANA, and Cloud Partner, a Microsoft Gold Partner and an Oracle Gold Partner managing Oracle E-Business Suite, PeopleSoft, JD Edwards and Hyperion applications across all industries for businesses of every size. Secure-24 has been named one of Computerworld’s 100 Best Places to Work in IT for six consecutive years.
Visit www.secure-24.com to learn more about Secure-24 products and services.
About Symmetry
Symmetry™ manages complex SAP implementations on a global scale for more than 200 of the world's leading enterprises. With its proprietary client-centric business model – The Symmetry Way – combined with the industry's most advanced SAP hosting platform and industry leading ControlPanelGRC® software suite, Symmetry delivers expert, high-touch SAP application management services across all deployment environments, including on-premise, hosted, and private, public and hybrid cloud. With more than 23 years in business, Symmetry has built a base of expertise unmatched by any other independent SAP service provider. An SAP partner since 2005, Symmetry is certified in SAP Hosting, Cloud and SAP HANA Operations. Symmetry is based in Brookfield, Wis. with locations across North America and Europe.
Learn more at https://symmetrycorp.com
Company names and service names stated in this press release are the trademarks, service marks and registered trademarks of each company.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190625006084/en/
Contact information
For more information
Masaki Nomoto, Osamu Inoue
Public Relations
Corporate Planning Department
NTT Communications
Tel: +81 3 6700 4010
Mail: pr-cp@ntt.com
IGNITE Consulting, on behalf of Secure-24
Kathleen Sullivan, 303-439-9365
secure-24@igniteconsultinginc.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex Receives CHMP Positive Opinion for ALYFTREK ® , a New Once-Daily CFTR Modulator for the Treatment of Cystic Fibrosis28.4.2025 09:03:00 EEST | Press release
Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for ALYFTREK®(deutivacaftor/tezacaftor/vanzacaftor)for the treatment of people with cystic fibrosis (CF) ages 6 years and older who have at least one non-class I mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. “Our goal has always been to serially innovate to help people with cystic fibrosis live healthier and longer lives. If approved, this new medicine would be indicated for people with CF ages 6 years and older with at least one non-class I mutation, meaning more patients would be eligible for a medicine that gets them closer to normal levels of sweat chloride,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. “CFTR modulators have already revolutionized the way we treat CF and I am encoura
Prilenia Enters into a Collaboration and License Agreement with Ferrer for the Commercialization and Co-Development of Pridopidine in Europe and Other Select Markets28.4.2025 08:02:00 EEST | Press release
Prilenia Therapeutics B.V., a biopharmaceutical company driven by an unwavering commitment to scientific excellence and accelerating progress for people affected by Huntington’s disease (HD) and amyotrophic lateral sclerosis (ALS), today announced that it has entered into a collaboration and license agreement with Ferrer for the commercialization and further development of pridopidine in Europe and other select markets. Pridopidine is a potent and highly selective, orally administered sigma-1 receptor (S1R) agonist designed to regulate key neuroprotective mechanisms often impaired in neurodegenerative diseases such as HD and ALS. Under the terms of the agreement, Prilenia will receive an upfront payment of approximately €80 million plus up to €45 million in near-term development, regulatory, and commercial milestones. The total deal is valued at up to approximately €500 million in upfront and total milestone payments. In addition, Prilenia will receive tiered double-digit royalties on
Ferrer Enters Into a Collaboration and License Agreement With Prilenia for the Commercialization and Co-Development of Pridopidine28.4.2025 08:00:00 EEST | Press release
Ferrer, an international B Corp pharmaceutical company with an increasing focus on rare neurological diseases, and Prilenia Therapeutics B.V.,a clinical-stage biotech company, have announced the signing of a strategic co-development and license agreement in which Ferrer obtains the rights to develop, manufacture and commercialize Pridopidine in the European Region, the Middle East and North African Region, the Southern African Region, the Central and South American Region, and the Commonwealth of Independent States Region. Pridopidine, a potent and highly selective, orally administered sigma-1 receptor agonist, designed to regulate key neuroprotective mechanisms that are often impaired in neurodegenerative diseases, is a promising candidate for the treatment of Huntington’s Disease (HD), a rare inherited neurodegenerative disease, with a high unmet medical need1. It has been studied in more than 1,700 people and long-term safety data of up to 7 years duration are available from previou
Innorna Announces FDA Rare Pediatric Disease and Orphan Drug Designations Granted to IN013 for Treatment of Wilson Disease27.4.2025 12:36:00 EEST | Press release
Innorna, a clinical-stage biotechnology company revolutionizing mRNA therapeutics with its innovative lipid nanoparticle (LNP) delivery technology, today announced the U.S. Food and Drug Administration (FDA) has granted both Rare Pediatric Disease Designation (RPDD) and Orphan Drug Designation (ODD) to its investigational mRNA therapy, IN013, for treating Wilson Disease (WD). This dual achievement accelerates the clinical development of IN013, advancing Innorna’s mission to deliver transformative therapies for WD patients. About FDA Designations The Rare Pediatric Disease Designation (RPDD) incentivizes therapies for serious or life-threatening diseases affecting fewer than 200,000 U.S. patients, primarily those aged 18 or younger. Sponsors may qualify for a Priority Review Voucher (PRV) upon approval to expedite FDA review of a subsequent drug application. The Orphan Drug Designation (ODD) supports therapies targeting rare diseases (affecting fewer than 200,000 U.S. patients) by provi
Everen Specialty Appoints Carla Greaves Chief Underwriting Officer25.4.2025 20:00:00 EEST | Press release
Everen Specialty, a Bermuda-based (re)insurer for energy markets worldwide, today announced the appointment of Carla Greaves as its new Chief Underwriting Officer (CUO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250425273777/en/ Carla Greaves Ms. Greaves will join the Executive Leadership Team of the Everen Group, based in the Bermuda office, later this year. She succeeds Jane Peterson, Interim CUO, who will continue in a consultancy capacity to facilitate the transition. With more than 30 years of underwriting and leadership experience in the (re)insurance industry, Ms. Greaves brings a wealth of expertise and a proven track record of success in the Casualty market where she is recognized for building high-performing teams, driving profitable growth, and successfully navigating complex market environments. Prior to joining Everen Specialty, Ms. Greaves held increasingly senior leadership positions, most recently servin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom